A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

NCT05795465 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Distress Syndrome, Acute

Interventions

DRUG: GEn-1124
DRUG: Placebo

Sponsor

GEn1E Lifesciences